Chicago Atlantic Provides Debt Financing to GF Sports & Entertainment
Chicago Atlantic Admin, LLC (“Chicago Atlantic”) announced that it acted as administrative agent on the funding of a senior secured credit facility for GF Capital Sports Holdings, LLC (“GF Sports & Entertainment”). GF Sports & Entertainment owns and operates the Dallas Open, a tennis tournament recently upgraded to ATP 500 status, which will host global professional tennis players at the Ford Center at The Star in Frisco, the Dallas Cowboys’ world corporate headquarters and training facility, beginning February 2025.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240613710439/en/
GF Sports & Entertainment owns and operates the Dallas Open, a tennis tournament recently upgraded to ATP 500 status. (Photo: Business Wire)
“We see alternative sports and sports tech as high-value emerging markets generally inelastic to broader economic trends. Tournaments upgraded from ATP 250 to ATP 500 status have historically experienced rapid financial progress as they attract elite competitors and fill mainstream venues. Coupling that success with the track record of GF Sports & Entertainment, we are extremely optimistic about the Dallas Open and proud to be a debt partner to this growing alternative asset class,” said Tony Cappell, Chicago Atlantic Founding Partner.
Increased accessibility of sports through social and streaming platforms has increased the efficiency at which a diverse array of sports can monetize their followings. This shift, coupled with improved economics of sports management, has driven increased demand and deal flow within the asset class, with niche sports identified as a strong area of opportunity.1
“Chicago Atlantic and GF Sports & Entertainment have a common mission to seize opportunities that others overlook, investing our talents, energies and resources in unique opportunities that deliver superior returns. We’ve watched Chicago Atlantic scale true strategic partnerships across the lower middle market and are thrilled to utilize their growth finance strategies during this time of unprecedented consumer demand,”said Gary Fuhrman, Chairman of GF Sports & Entertainment.
1 S&P Global Market Intelligence, March 2024.
About Chicago Atlantic
Chicago Atlantic is a private markets alternative investment manager focused on industries and companies where demand for capital exceeds traditional supply. Founding Partners John Mazarakis, Tony Cappell and Andreas Bodmeier established Chicago Atlantic to provide capital solutions to state-licensed cannabis operators. The firm’s private investment strategies have grown to include opportunistic credit, private equity, digital mining and impact investing, with focuses on loans to esoteric industries, specialty asset-based loans, liquidity solutions and growth and technology finance. Chicago Atlantic has closed over $2.1 billion in credit facilities to date. Chicago Atlantic’s team of 85 professionals has offices in Miami, Florida and Chicago, Illinois. For more information on Chicago Atlantic’s financing products, visit chicagoatlantic.com
About GF Sports & Entertainment
GF Sports & Entertainment is a live events and sports entertainment company established by the New York-based private equity firm, GF Capital. In addition to the Dallas Open, the company owns and operates the ATP 250 Atlanta Open (taking place for the final time July 2024), the National Lacrosse League (NLL) team the Ottawa Black Bears and The World Long Drive Tour.The firm produces memorable events and riveting competitions, unique concepts and global content, but above all, vital and enduring franchises. To learn more, visit GFsportsandentertainment.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240613710439/en/
Contacts
Alise M. Edgcomb
Managing Director, Public Relations
(419) 202 – 3988
aedgcomb@chicagoatlantic.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kolmar Korea Named One of the TIME’s World’s Best Companies for Sustainable Growth26.12.2024 15:00:00 CET | Press Release
Kolmar Korea (KRX: 024720) has been recognized by TIME Magazine as one of the World’s Best Companies for Sustainable Growth 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241226863828/en/ Kolmar Korea on TIME's World's Best Companies in Sustainable Growth 2025 (Image: Kolmar Korea) On November 27, TIME, in collaboration with a global market research firm Statista, unveiled a list of the top 500 companies worldwide, demonstrating exceptional sustainable growth. Kolmar Korea took place 125th around the globe and 6th among Korean companies. Notably, it was the only Korean cosmetics company on the list, which featured a total of 23 Korean companies. The rankings were based on an evaluation of revenue growth, financial stability, and environmental impact, each contributing equally to a final score out of 100 points. TIME and Statista analyzed 3,000 major companies from 150 countries, focusing exclusively on those with trans
Seoul Semiconductor: Philips Lighting Products Ordered to Recall 7-Year-Old Items26.12.2024 08:00:00 CET | Press Release
The German District Court of Düsseldorf, on November 19 ruled in favor of Seoul Semiconductor (KOSDAQ:046890) in the patent infringement lawsuits, and also ordered that products manufactured by Philips Lighting and sold since March 2017 be recalled and destroyed. The Court also ruled that a fine of up to €250,000 would be imposed for each violation of this order. On December 17, the German Federal Patent Court also affirmed the validity of these patents, which solidifies the strength of many related patents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225151382/en/ Application Examples with CRI 70 or Higher (Photo: Seoul Semiconductor) These court orders relate to the core technology used to achieve CRI 70 (Color Rendering Index 70%) or higher, applicable to all home lighting, automotive lighting products, IT flash, and backlights. Since the effects of these judgments are applicable to all products infringing on the pa
ispace-EUROPE and the Italian Space Agency (ASI) Sign Payload Services Agreement to Transport a Laser Retroreflector Array (LaRA2) on the Moon Surface26.12.2024 08:00:00 CET | Press Release
ispace EUROPE S.A. (ispace-EUROPE), the Luxembourg-based subsidiary of ispace, inc., and the Italian Space Agency (ASI) have signed a payload services agreement to transport a Laser Retroreflector Array (LaRA2) to enable accurate position measurements on the Moon via laser ranging experiments, the two organizations announced today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225137548/en/ The shape of LaRA2, a palm-sized dome (Photo: Business Wire) The agreement marks the first full-scale contract between ispace-EUROPE and ASI, with both organizations looking to joint future lunar development. LaRA2 is a small, robust, and lightweight instrument built to work without any power source and to survive the harsh surface conditions on the Moon for an extended period of time. It features a precise array of retroreflectors (corner cube prisms) designed to reflect laser beams directly back to their source, regardless of the an
Datopotamab Deruxtecan Application in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer Voluntarily Withdrawn24.12.2024 08:00:00 CET | Press Release
Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have voluntarily withdrawn the marketing authorization application (MAA) in the EU for datopotamab deruxtecan (Dato-DXd) for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) based on the TROPION-Lung01 phase 3 trial. The decision to withdraw the MAA was informed by feedback from the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA). Daiichi Sankyo and AstraZeneca will continue to work to bring datopotamab deruxtecan to patients with lung cancer in the EU who can benefit and are committed to unlocking the potential of this medicine in lung cancer through our robust clinical development program which includes seven pivotal trials in various lung cancer settings. Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed by Dai
Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 1323.12.2024 22:05:00 CET | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 10:30 a.m. ET/7:30 a.m. PT. A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website. About Vertex Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom